Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HD2000: Comparison of ABVD, BEACOPP, and COPPEBVCAD in Advanced Hodgkin's Lymphoma
NCT00443677Phase 3Completed
- Sponsor
- Gruppo Italiano Studio Linfomi
- Start
- Apr 2000
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands, Covalent Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cyclophosphamide, lomustine, vindesine, melphalan, prednisone in Hodgkin lymphoma (HL), sponsored by Gruppo Italiano Studio Linfomi. Started Apr 2000; status: completed.
02
Drugs
cyclophosphamidelomustinevindesinemelphalanprednisone
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00443677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00443677.